News

You are here

VAX-ID intradermal drug delivery device
Timothi Van Mulder will present Novosanis' breakthrough results on the development of a painless injection device for children at 12 th Vaccine Congress in Budapest, Hungary from September...
Andrès Nieto Porras
The Summer Edition of our NewsTalks is live! Read updates on VAX-ID, urine as a sample for detection of breast cancer and the live testing of our next generation Colli-Pee suited for home-...
IUSTI2018
Novosanis attended IUSTI2018 from June 26 to June 30 in Dublin, Ireland. Our Colli-Pee device suited for first-void urine collection allowing for improved detection of STIs was on display...
We care about your privacy
We'd love to stay connected! And for sure get connected to new people as well. Opt in on our NewsTalks and Communications.
Knowledge for Growth
Novosanis is teaming up with Voxdale at KfG2018! We are excited to share our research data and showcase our medical device platforms, VAX-ID™ and Colli-Pee™. See you there!
World Health Day 2018
April 7th marks World Health Day
Colli-Pee
Colli-Pee US FDA registered
Novosanis will present its VAX-ID™ device platform during BioJapan
Prostate cancer is the most common male cancer, with around 400,000 new cases every year in Europe.
For a healthy life
Urology week is an initiative from the European Association for Urology (EAU) that tries to raise awareness for urological care and its importance in improving quality of life.

Pages